{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "regularMarketChangePercent": -0.81300735, "regularMarketPrice": 1.22, "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "exchange": "FRA", "shortName": "ADAGENE INC. SP.ADR", "longName": "Adagene Inc.", "messageBoardId": "finmb_118162960", "exchangeTimezoneName": "Europe/Berlin", "marketState": "REGULAR", "firstTradeDateMilliseconds": 1613631600000, "priceHint": 4, "regularMarketChange": -0.00999999, "regularMarketTime": 1683875702, "regularMarketDayHigh": 1.22, "regularMarketDayRange": "1.22 - 1.22", "regularMarketDayLow": 1.22, "regularMarketVolume": 220, "regularMarketPreviousClose": 1.23, "bid": 1.22, "ask": 1.34, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 1.22, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.33500004, "fiftyTwoWeekLowChangePercent": 0.37853113, "fiftyTwoWeekRange": "0.885 - 6.0", "fiftyTwoWeekHighChange": -4.7799997, "fiftyTwoWeekHighChangePercent": -0.7966666, "fiftyTwoWeekLow": 0.885, "fiftyTwoWeekHigh": 6.0, "earningsTimestamp": 1680038700, "earningsTimestampStart": 1680038700, "earningsTimestampEnd": 1680038700, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.71, "epsForward": -2.17, "epsCurrentYear": -1.65, "priceEpsCurrentYear": -0.73939395, "sharesOutstanding": 43772700, "bookValue": 1.933, "fiftyDayAverage": 1.3116, "fiftyDayAverageChange": -0.09159994, "fiftyDayAverageChangePercent": -0.06983832, "twoHundredDayAverage": 1.30205, "twoHundredDayAverageChange": -0.082049966, "twoHundredDayAverageChangePercent": -0.06301599, "marketCap": 56950088, "forwardPE": -0.562212, "priceToBook": 0.63114333, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.7 - Buy", "tradeable": false, "cryptoTradeable": false, "symbol": "978.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Building C14", "address2": "4th Floor No. 218, Xinghu Street Suzhou Industrial Park", "city": "Suzhou", "zip": "215123", "country": "China", "phone": "86 512 8777 3632", "website": "https://www.adagene.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Adagene Inc., a clinical stage immunotherapy company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti- CD137 IgG4 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid tumors and non-Hodgkin's lymphoma; ADG126, a fully-human anti-CTLA-4 mAb that is in Phase 1 clinical trial for the treatment advanced/metastatic solid tumors; and ADG116, a human ligand-blocking anti-CTLA-4 mAb, which is in Phase I clinical trial for the treatment of advanced metastatic solid tumors. It also offers ADG104, an anti-PD-L1 mAb that is in Phase 2 clinical development; ADG125, a novel anti-CSF-1R mAb, which is in Phase I clinical trial; ADG206, a masked, Fc engineered anti-CD137 agonistic POWERbody, which is in preclinical; ADG153, a masked anti-CD47 IgG1 SAFEbody, which is in preclinical stage for the treatment hematologic and solid tumors; ADG138, novel HER2xCD3 POWERbody, which is in preclinical for the treatment HER2-expressing solid tumors; and ADG152, a CD20xCD3 POWERbody, which is in preclinical stage for the treatment off-tumor toxicities. The company was incorporated in 2011 and is headquartered in Suzhou, China.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Peter P.  Luo Ph.D.", "age": 56, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1966, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Man Kin  Tam M.B.A.", "age": 45, "title": "CFO & Director", "yearBorn": 1977, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Fangyong  Du Ph.D.", "age": 52, "title": "CTO & Director", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jc  Xu M.D., Ph.D.", "age": 57, "title": "Chief Scientific Officer", "yearBorn": 1965, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Ami Celeste Knoefler", "title": "VP of Investor Relations & Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Ling  Zhou", "title": "Head of HR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Qinghai  Zhao", "age": 61, "title": "Chief Manufacturing Officer", "yearBorn": 1961, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Yan  Li M.B.A.", "age": 47, "title": "Sr. VP of Bioinformatics & Information Technology", "yearBorn": 1975, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Xiaohong  She", "age": 55, "title": "Sr. VP & Head of Clinical Operations", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Guizhong  Liu Ph.D.", "age": 51, "title": "Head of Biology & Pharmacology", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}